Avalon BioVentures — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
AristaMD is a technology-enabled clinical services provider that connects primary care physicians with board-certified specialists through eConsults to improve access to specialty care and reduce costs.
Digital HealthEnterprise SoftwareHealthtechSaaSSan Diego, US
Keith Pinter(Chief Executive Officer)Julia Jezmir(President and Chief Medical Officer)Brooke LeVasseur(Executive Officer, Director)Craig Cimini(Director)
BoardJohn Kuelper(Director)Tighe Reardon(Executive Officer, Director)
Board seatJay B. Lichter· per SEC Form D · $1.4M raise · filed Mar 2016
BiotechLa Jolla, US
Jay Lichter(Director)Court Turner(Executive Officer, Director)
BoardTighe Reardon(Executive Officer, Director)
Board seatJay B. Lichter· per SEC Form D · $5.1M raise · filed Nov 2016
Clinical-stage biotech expanding the genetic alphabet with synthetic nucleotides; acquired by Sanofi for $2.5B in 2020.
La Jolla, US
Board seatJay B. Lichter· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.